Related Experiment Video
Updated: Jun 11, 2025

05:45
Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example
Published on: March 11, 2020
8.7K
An Iterative Approach to Polish the Nanopore Sequencing Basecalling for Therapeutic RNA Quality Control
Ziyuan Wang1,2, Mei-Juan Tu3,2, Ziyang Liu1,4,2
1Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona, USA.
Biorxiv : the Preprint Server for Biology
|September 30, 2024
Summary
This study introduces an iterative method to improve nanopore sequencing accuracy for modified nucleic acids. The approach enhances basecalling for therapeutic RNAs, crucial for vaccine mRNA quality control and RNA interference (RNAi) drug development.
Area of Science:
- Molecular Biology
- Bioinformatics
- Genomics
Background:
- Nanopore sequencing is a powerful tool for direct nucleic acid analysis.
- Nucleotide modifications introduce artifacts in nanopore sequencing, compromising basecalling accuracy.
- Accurate basecalling is essential for analyzing modified nucleic acids, including therapeutic RNAs.
Purpose of the Study:
- To develop and validate an iterative approach for polishing basecalling results affected by nucleotide modifications.
- To enhance the accuracy of nanopore sequencing for both synthetic and native RNA molecules.
- To apply the improved basecalling method for critical applications in therapeutic RNA analysis.
Main Methods:
- Development of an iterative algorithm to correct basecalling errors caused by nucleotide modifications.
- Testing the approach on artificially synthesized and real-world RNA samples.
- Application of the method to analyze vaccine messenger RNAs (mRNAs) and RNA interference (RNAi) molecules.
Main Results:
- The iterative approach significantly improves basecalling accuracy in the presence of nucleotide modifications.
- Demonstrated efficacy on both synthesized and naturally occurring RNA molecules.
- Successful application for purity and integrity assessment of vaccine mRNAs and identification of modification sites in novel RNAi therapeutics.
Conclusions:
- The developed iterative method effectively corrects nanopore sequencing artifacts from nucleotide modifications.
- This approach provides a reliable basis for precise basecalling of therapeutic RNAs.
- Enables accurate quantification of vaccine mRNA quality and characterization of novel RNA-based therapeutics.

